Dominik Gulyás

Preclinical evaluation of naturally derived viral nucleic acids in combination cancer immunotherapy

Abstract Effective cancer immunotherapy often requires coordinated activation of innate and adaptive immune responses. While the previous studies have primarily focused on whole oncolytic viruses, synthetic or engineered viral nucleic acids, or inactivated viral particles, the th...